{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:51:29Z","timestamp":1779389489558,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2000,9,20]],"date-time":"2000-09-20T00:00:00Z","timestamp":969408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1038\/35036374","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:47:57Z","timestamp":1027673277000},"page":"737-744","source":"Crossref","is-referenced-by-count":2245,"title":["Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis"],"prefix":"10.1038","volume":"2","author":[{"given":"Gabriele","family":"Bergers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Brekken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiennu H.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tanzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyoshi","family":"Itohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Werb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Hanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,9,20]]},"reference":[{"key":"BFncb1000_737_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"BFncb1000_737_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. Tumour angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182\u20131186 (1971).","journal-title":"N. Engl. J. Med."},{"key":"BFncb1000_737_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 86, 353\u2013364 (1996).","journal-title":"Cell"},{"key":"BFncb1000_737_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0065-230X(08)60862-3","volume":"69","author":"N Bouck","year":"1996","unstructured":"Bouck, N., Stellmach, V. & Hsu, S. C. How tumours become angiogenic. Adv. Cancer Res. 69, 135\u2013174 (1996).","journal-title":"Adv. Cancer Res."},{"key":"BFncb1000_737_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan, D. Heritable formation of pancreatic \u03b2-cell tumours in transgenic mice harboring recombinant insulin\/simian virus 40 oncogenes. Nature 315, 115\u2013122 (1985).","journal-title":"Nature"},{"key":"BFncb1000_737_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/339058a0","volume":"339","author":"J Folkman","year":"1989","unstructured":"Folkman, J., Watson, K., Ingber, D. & Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58\u201361 (1989).","journal-title":"Nature"},{"key":"BFncb1000_737_CR7","first-page":"97","volume":"237","author":"HF Dvorak","year":"1999","unstructured":"Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F. & Dvorak, A. M. Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237, 97\u2013132 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFncb1000_737_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF03401737","volume":"4","author":"RS Kerbel","year":"1998","unstructured":"Kerbel, R. S., Viloria-Petit, A., Okada, F. & Rak, J. Establishing a link between oncogenes and tumour angiogenesis. Mol. Med. 4, 286\u2013295 (1998).","journal-title":"Mol. Med."},{"key":"BFncb1000_737_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1046\/j.1440-1681.1999.02992.x","volume":"26","author":"DV Faller","year":"1999","unstructured":"Faller, D. V. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol. 26, 74\u201384 (1999).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"BFncb1000_737_CR10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/S0959-8049(96)00401-7","volume":"32A","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D., Christofori, G., Naik, P. & Arbeit, J. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur. J. Cancer 32A, 2386\u20132393 (1996).","journal-title":"Eur. J. Cancer"},{"key":"BFncb1000_737_CR11","first-page":"1760","volume":"9","author":"G Christofori","year":"1995","unstructured":"Christofori, G., Naik, P. & Hanahan, D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumourigenesis. Mol. Endocrinol. 9, 1760\u20131770 (1995).","journal-title":"Mol. Endocrinol."},{"key":"BFncb1000_737_CR12","first-page":"765","volume":"57","author":"WG Roberts","year":"1997","unstructured":"Roberts W. G. & Palade, G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57, 765\u201372 (1997).","journal-title":"Cancer Res."},{"key":"BFncb1000_737_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.neo.7900006","volume":"1","author":"P Vajkoczy","year":"1999","unstructured":"Vajkoczy, P. et al. Inhibition of tumour growth, angiogenesis, and microcirculation by the novel flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1, 31\u201341 (1999).","journal-title":"Neoplasia"},{"key":"BFncb1000_737_CR14","first-page":"1952","volume":"58","author":"RA Brekken","year":"1998","unstructured":"Brekken, R. A., Huang, X., King, S. W. & Thorpe, P. E. Vascular endothelial growth factor as a marker of tumour endothelium. Cancer Res. 58, 1952\u20131959 (1998).","journal-title":"Cancer Res."},{"key":"BFncb1000_737_CR15","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1073\/pnas.94.22.12081","volume":"94","author":"SY Cheng","year":"1997","unstructured":"Cheng, S. Y., Nagane, M., Huang, H. S. & Cavenee, W. K. Intracerebral tumour-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc. Natl Acad. Sci. USA 94, 12081\u201312087 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb1000_737_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439\u2013442 (1996).","journal-title":"Nature"},{"key":"BFncb1000_737_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435\u2013439 (1996).","journal-title":"Nature"},{"key":"BFncb1000_737_CR18","doi-asserted-by":"publisher","first-page":"29568","DOI":"10.1074\/jbc.274.41.29568","volume":"274","author":"MS O'Reilly","year":"1999","unstructured":"O'Reilly, M. S., Widerschain, D., Stetler-Stevenson, W. G., Folkman, J. & Moses, M. A. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. 274, 29568\u201329571 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFncb1000_737_CR19","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1016\/S0959-8049(96)00398-X","volume":"32A","author":"DC Talbot","year":"1996","unstructured":"Talbot, D. C. & Brown, P. D. Experimental and clinical studies on the use of matrix metalloprotease inhibitors for the treatment of cancer. Eur. J. Cancer 32A, 2528\u20132533. (1996).","journal-title":"Eur. J. Cancer"},{"key":"BFncb1000_737_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1699-0463.1999.tb01541.x","volume":"107","author":"PD Brown","year":"1999","unstructured":"Brown, P. D. Clinical studies with matrix metalloprotease inhibitors. Acta Pathologica Microbiologica et Immunologica Sacndinavica 107, 174\u201380 (1999).","journal-title":"Acta Pathologica Microbiologica et Immunologica Sacndinavica"},{"key":"BFncb1000_737_CR21","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1248\/cpb.43.1883","volume":"43","author":"K Tamaki","year":"1995","unstructured":"Tamaki, K. et al. Synthesis and structure\u2013activity relationships of gelatinase inhibitors derived from matlystatins. Chem. Pharmaceut. Bull. 43, 1883\u20131893 (1995).","journal-title":"Chem. Pharmaceut. Bull."},{"key":"BFncb1000_737_CR22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.284.5415.808","volume":"284","author":"G Bergers","year":"1999","unstructured":"Bergers, G., Javaherian, K., Lo, K-M., Folkman, J. & Hanahan, D. Differential effects of angiogenesis inhibitors on distinct stages of carcinogenesis. Science 284, 808\u2013812 (1999).","journal-title":"Science"},{"key":"BFncb1000_737_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu, T.H. et al. MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411\u2013422 (1998).","journal-title":"Cell"},{"key":"BFncb1000_737_CR24","doi-asserted-by":"publisher","first-page":"22389","DOI":"10.1074\/jbc.272.36.22389","volume":"272","author":"T Itoh","year":"1997","unstructured":"Itoh, T. et al. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloprotease 2)-deficient mice. J. Biol. Chem. 272, 22389\u201322392 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFncb1000_737_CR25","first-page":"1048","volume":"58","author":"T Itoh","year":"1998","unstructured":"Itoh, T. et al. Reduced angiogenesis and tumour progression in gelatinase A-deficient mice. Cancer Res. 58, 1048\u20131051 (1998).","journal-title":"Cancer Res."},{"key":"BFncb1000_737_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ng1297-439","volume":"17","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet, P. et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Gen. 17, 439\u2013444 (1997).","journal-title":"Nature Gen."},{"key":"BFncb1000_737_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00046361","volume":"9","author":"I Vlodavsky","year":"1990","unstructured":"Vlodavsky, I. et al. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumour metastasis and angiogenesis. Cancer Metastasis Rev., 9, 203\u2013226 (1990).","journal-title":"Cancer Metastasis Rev."},{"key":"BFncb1000_737_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/10525","volume":"7","author":"MD Hulett","year":"1999","unstructured":"Hulett, M. D. et al. Cloning of mammalian heparanase, an important enzyme in tumour invasion and metastasis. Nature Med. 7, 803\u2013809 (1999).","journal-title":"Nature Med."},{"key":"BFncb1000_737_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/10518","volume":"7","author":"I Vlodavsky","year":"1999","unstructured":"Vlodavsky, I. et al. Mammalian heparanase: gene cloning, expression and function in tumour progression and metastasis. Nature Med. 7, 793\u2013802 (1999).","journal-title":"Nature Med"},{"key":"BFncb1000_737_CR30","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","volume":"13","author":"LM Coussens","year":"1999","unstructured":"Coussens, L. M. et al. Inflammatory mast cells upregulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382\u20131397 (1999).","journal-title":"Genes Dev."},{"key":"BFncb1000_737_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/9467","volume":"5","author":"H-P Gerber","year":"1999","unstructured":"Gerber, H-P. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med. 5, 623\u2013628 (1999).","journal-title":"Nature Med."},{"key":"BFncb1000_737_CR32","doi-asserted-by":"crossref","unstructured":"Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell (in the press).","DOI":"10.1016\/S0092-8674(00)00139-2"},{"key":"BFncb1000_737_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1749-6632.1999.tb07687.x","volume":"878","author":"S Zucker","year":"1999","unstructured":"Zucker, S. et al. Measurement of matrix metalloprotease and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann. NY Acad. Sci. 878, 212\u2013227 (1999).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFncb1000_737_CR34","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1073\/pnas.97.8.3884","volume":"97","author":"J Fang","year":"2000","unstructured":"Fang, J. et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumour model. Proc. Natl Acad. Sci. USA 97, 3884\u20133889 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb1000_737_CR35","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1073\/pnas.060037197","volume":"97","author":"Z Zhou","year":"2000","unstructured":"Zhou, Z. et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl Acad. Sci. USA 97, 4052\u20134057 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb1000_737_CR36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu, Q. & Stamenkovic, I. Cell surface-localized metalloproteinase-9 proteolyically activates TGF-beta and promotes tumour invasion and angiogenesis. Genes Dev. 14, 163\u2013176 (2000).","journal-title":"Genes Dev."},{"key":"BFncb1000_737_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/32433","volume":"392","author":"AK Perl","year":"1998","unstructured":"Perl, A. K. et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190\u2013193 (1998).","journal-title":"Nature"},{"key":"BFncb1000_737_CR38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1242\/dev.114.2.447","volume":"114","author":"O Behrendtsen","year":"1992","unstructured":"Behrendtsen, O., Alexander, C. M. & Werb, Z. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114, 447\u2013456 (1992).","journal-title":"Development"},{"key":"BFncb1000_737_CR39","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1101\/gad.10.17.2105","volume":"10","author":"P Naik","year":"1996","unstructured":"Naik, P., Karrim, J. & Hanahan, D. The rise and fall of apoptosis during multistage tumourigenesis: downmodulation contributes to progression from angiogenic progenitors. Genes Dev. 10, 2105\u20132116 (1996).","journal-title":"Genes Dev."},{"key":"BFncb1000_737_CR40","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1016\/S0021-9258(17)35859-3","volume":"261","author":"GS Herron","year":"1986","unstructured":"Herron, G. S., Werb, Z., Dwyer, K. & Banda, M. J. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenases and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261, 2810\u20132813 (1986).","journal-title":"J. Biol. Chem."},{"key":"BFncb1000_737_CR41","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/S0021-9258(17)35860-X","volume":"261","author":"GS Herron","year":"1986","unstructured":"Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J. & Werb, Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem. 261, 2814\u20132818 (1986).","journal-title":"J. Biol. Chem."},{"key":"BFncb1000_737_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1242\/dev.112.2.439","volume":"112","author":"RS Talhouk","year":"1991","unstructured":"Talhouk, R. S., Chin, J. R., Unemori, E. N., Werb, Z. & Bissell, M. J. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 112, 439\u2013449 (1991).","journal-title":"Development"},{"key":"BFncb1000_737_CR43","first-page":"6071","volume":"55","author":"S Parangi","year":"1995","unstructured":"Parangi, S., Dietrich, W., Christofori, G., Lander, E. S. & Hanahan, D. Tumour suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumourigenesis in a transgenic model of islet cell carcinoma. Cancer Res. 55, 6071\u20136076 (1995).","journal-title":"Cancer Res."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncb1000_737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncb1000_737","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncb1000_737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:20:08Z","timestamp":1684437608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncb1000_737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,20]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["BFncb1000_737"],"URL":"https:\/\/doi.org\/10.1038\/35036374","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,20]]}}}